TORONTO, Jan. 15, 2021 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE:MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven pharmaceutical-quality cannabis extraction, distillation and derivative products, today announced the appointment of Warren Everitt to its Board of Directors (the “Board”), effective immediately.

Follow this link:
MediPharm Labs Appoints Warren Everitt, CEO Australia Pacific, to Board of Directors

Related Post

Leave a comment

Your email address will not be published. Required fields are marked *